Exchange: NASDAQ·Updated 04:15 PM EST

SNOA News

News
all
press releases
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue
Sonoma Pharmaceuticals reported record Q1 revenue, narrow loss, doubled U.S. sales and achieved positive adjusted EBITDA for the first time.read more...
Benzinga
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue
Sonoma Pharmaceuticals reported record Q1 revenue, narrow loss, doubled U.S. sales and achieved positive adjusted EBITDA for the first time.read more...
Benzinga
More News
Sonoma Pharmaceuticals (SNOA) shares slide following a $4M public offering priced at $1.35. Get the latest stock news here.read more...
Benzinga
Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its burn relief hydrogel in CVS and Walmart stores.read more...
Benzinga
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks

Advertisement|Remove ads.